Journal of the Korean Society of Radiology (대한영상의학회지)

The Korean Society of Radiology (대한영상의학회)
권호 표지
DOI QR코드

DOI QR Code

MRI-Guided Breast Intervention: Biopsy and Needle Localization

자기공명영상 유도하 유방의 중재적시술: 조직생검술 및 침위치결정술

  • Ga Eun Park (Department of Radiology, College of Medicine, Seoul St. Mary's Hospital, The Catholic University of Korea) ;
  • Jeongmin Lee (Department of Radiology, College of Medicine, Seoul St. Mary's Hospital, The Catholic University of Korea) ;
  • Bong Joo Kang (Department of Radiology, College of Medicine, Seoul St. Mary's Hospital, The Catholic University of Korea) ;
  • Sung Hun Kim (Department of Radiology, College of Medicine, Seoul St. Mary's Hospital, The Catholic University of Korea)
  • 박가은 (가톨릭대학교 의과대학 서울성모병원 영상의학과) ;
  • 이정민 (가톨릭대학교 의과대학 서울성모병원 영상의학과) ;
  • 강봉주 (가톨릭대학교 의과대학 서울성모병원 영상의학과) ;
  • 김성헌 (가톨릭대학교 의과대학 서울성모병원 영상의학과)
  • Received : 2022.12.01
  • Accepted : 2023.03.14
  • Published : 2023.03.01
Download PDF
⟨ Previous Next ⟩

Abstract

In Korea, the number of institutions providing breast MRI, as well as the number of breast MRIs, has recently increased. However, MRI-guided procedures, including biopsy and needle localization, are rarely performed compared to ultrasound-guided or stereotactic biopsy. As breast MRI has high sensitivity but limited specificity, lesions detected only on MRI require pathologic confirmation through MRI-guided biopsy or surgical excision with MRI-guided needle localization. Thus, we aimed to review MRI-guided procedures, including their indications, techniques, procedural considerations, and limitations.

국내에 자기공명영상의 보급의 증가와 함께 유방 자기공명영상의 건수도 지속적으로 증가하고 있다. 하지만 이에 비해 자기공명영상 유도하 조직생검술 및 침위치결정술과 같은 유방의 중재적 시술은 초음파 유도하 시술이나 입체정위생검술에 비해 많이 이루어지지 않는다. 유방 자기공명영상은 다른 유방 영상 검사들에 비해 높은 민감도를 보이는 검사법이지만 그 특이도는 제한되는 검사법이기 때문에, 자기공명영상에서만 발견된 병변들은 자기공명영상 유도하 조직생검술이나 자기공명영상 유도하 침위치결정술을 통한 수술적 절제를 통하여 병리적 진단이 이루어져야 한다. 이러한 배경을 바탕으로, 본 종설에서는 자기공명영상 유도하 유방의 중재적 시술들의 적응증, 시술 방법, 시술 과정에서의 여러 고려 사항 및 제한점들에 대해 다루고자 한다.

Keywords

References

  1. Boetes C, Mus RD, Holland R, Barentsz JO, Strijk SP, Wobbes T, et al. Breast tumors: comparative accuracy of MR imaging relative to mammography and US for demonstrating extent. Radiology 1995;197:743-747
  2. Gavenonis SC, Roth SO. Role of magnetic resonance imaging in evaluating the extent of disease. Magn Reson Imaging Clin N Am 2010;18:199-206, vii-viii
  3. Mann RM. The effectiveness of MR imaging in the assessment of invasive lobular carcinoma of the breast. Magn Reson Imaging Clin N Am 2010;18:259-276, ix
  4. Peters NH, Borel Rinkes IH, Zuithoff NP, Mali WP, Moons KG, Peeters PH. Meta-analysis of MR imaging in the diagnosis of breast lesions. Radiology 2008;246:116-124
  5. Kuhl C, Weigel S, Schrading S, Arand B, Bieling H, Konig R, et al. Prospective multicenter cohort study to refine management recommendations for women at elevated familial risk of breast cancer: the EVA trial. J Clin Oncol 2010;28:1450-1457
  6. Berg WA, Zhang Z, Lehrer D, Jong RA, Pisano ED, Barr RG, et al. Detection of breast cancer with addition of annual screening ultrasound or a single screening MRI to mammography in women with elevated breast cancer risk. JAMA 2012;307:1394-1404
  7. Othman E, Wang J, Sprague BL, Rounds T, Ji Y, Herschorn SD, et al. Comparison of false positive rates for screening breast magnetic resonance imaging (MRI) in high risk women performed on stacked versus alternating schedules. Springerplus 2015;4:77
  8. Saslow D, Boetes C, Burke W, Harms S, Leach MO, Lehman CD, et al. American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin 2007;57:75-89
  9. American College of Radiology. ACR practice parameter for the performance of contrast-enhanced magnetic resonance imaging (MRI) of the breast 2018. Available at. https://www.acr.org/-/media/acr/files/practice-parameters/mr-contrast-breast.pdf. Accessed November 1, 2022
  10. American College of Radiology. ACR BI-RADS atlas: breast imaging reporting and data system. Reston, VA: American College of Radiology 2013
  11. McGrath AL, Price ER, Eby PR, Rahbar H. MRI-guided breast interventions. J Magn Reson Imaging 2017;46:631-645
  12. Han BK, Schnall MD, Orel SG, Rosen M. Outcome of MRI-guided breast biopsy. AJR Am J Roentgenol 2008;191:1798-1804
  13. Cha SY, Ko EY, Han BK, Ko ES, Choi JS, Park KW, et al. Magnetic resonance imaging-guided breast biopsy in Korea: a 10-year follow-up experience. J Breast Cancer 2021;24:377-388
  14. Arazi-Kleinman T, Skair-Levy M, Slonimsky E, Maly B, Uziely B, Libson E, et al. Journal club: is screening MRI indicated for women with a personal history of breast cancer? Analysis based on biopsy results. AJR Am J Roentgenol 2013;201:919-927
  15. Kang BJ, Kim SH, Choi JJ, Lee JH, Cha ES, Kim HS, et al. The clinical and imaging characteristics of breast cancers in patients with interstitial mammoplasty. Arch Gynecol Obstet 2010;281:1029-1035
  16. An Y, Kim S, Kang B, Lee J. Usefulness of magnetic resonance imaging-guided vacuum-assisted breast biopsy in Korean women: a pilot study. World J Surg Oncol 2013;11:200
  17. Spick C, Baltzer PA. Diagnostic utility of second-look US for breast lesions identified at MR imaging: systematic review and meta-analysis. Radiology 2014;273:401-409
  18. Heywang-Kobrunner SH, Sinnatamby R, Lebeau A, Lebrecht A, Britton PD, Schreer I; Consensus Group. Interdisciplinary consensus on the uses and technique of MR-guided vacuum-assisted breast biopsy (VAB): results of a European consensus meeting. Eur J Radiol 2009;72:289-294
  19. Noroozian M, Gombos EC, Chikarmane S, Georgian-Smith D, Raza S, Denison CM, et al. Factors that impact the duration of MRI-guided core needle biopsy. AJR Am J Roentgenol 2010;194:W150-W157
  20. Yun BL, Kim SM, Jang M, Cho N, Moon WK, Kim HH. Breast magnetic resonance imaging-guided biopsy. J Korean Soc Radiol 2016;74:351-360
  21. Preibsch H, Baur A, Wietek BM, Kramer B, Staebler A, Claussen CD, et al. Vacuum-assisted breast biopsy with 7-gauge, 8-gauge, 9-gauge, 10-gauge, and 11-gauge needles: how many specimens are necessary? Acta Radiol 2015;56:1078-1084
  22. Price ER. Magnetic resonance imaging-guided biopsy of the breast: fundamentals and finer points. Magn Reson Imaging Clin N Am 2013;21:571-581
  23. Funaro K, Prather A, Niell B, Jared Weinfurtner R. Tissue marker migration after MRI-guided breast biopsy: migration frequency and associated factors. Breast J 2020;26:440-445
  24. Liberman L, Dershaw DD, Morris EA, Abramson AF, Thornton CM, Rosen PP. Clip placement after stereotactic vacuum-assisted breast biopsy. Radiology 1997;205:417-422
  25. Lee SG, Piccoli CW, Hughes JS. Displacement of microcalcifications during stereotactic 11-gauge directional vacuum-assisted biopsy with marking clip placement: case report. Radiology 2001;219:495-497
  26. Rosen EL, Vo TT. Metallic clip deployment during stereotactic breast biopsy: retrospective analysis. Radiology 2001;218:510-516
  27. Le-Petross HT, Hess KR, Knudtson JD, Lane DL, Moseley TW, Geiser WR, et al. Effect of mammography on marker clip migration after stereotactic-guided core needle breast biopsy. Curr Probl Diagn Radiol 2017;46: 410-414
  28. Esserman LE, Cura MA, DaCosta D. Recognizing pitfalls in early and late migration of clip markers after imaging-guided directional vacuum-assisted biopsy. Radiographics 2004;24:147-156
  29. Jain A, Khalid M, Qureshi MM, Georgian-Smith D, Kaplan JA, Buch K, et al. Stereotactic core needle breast biopsy marker migration: an analysis of factors contributing to immediate marker migration. Eur Radiol 2017;27:4797-4803
  30. Niell BL, Lee JM, Johansen C, Halpern EF, Rafferty EA. Patient outcomes in canceled MRI-guided breast biopsies. AJR Am J Roentgenol 2014;202:223-228
  31. Johnson KS, Baker JA, Lee SS, Soo MS. Cancelation of MRI guided breast biopsies for suspicious breast lesions identified at 3.0 T MRI: reasons, rates, and outcomes. Acad Radiol 2013;20:569-575
  32. Hefler L, Casselman J, Amaya B, Heinig A, Alberich T, Koelbl H, et al. Follow-up of breast lesions detected by MRI not biopsied due to absent enhancement of contrast medium. Eur Radiol 2003;13:344-346
  33. Heller SL, Elias K, Gupta A, Greenwood HI, Mercado CL, Moy L. Outcome of high-risk lesions at MRI-guided 9-gauge vacuum- assisted breast biopsy. AJR Am J Roentgenol 2014;202:237-245
  34. Rauch GM, Dogan BE, Smith TB, Liu P, Yang WT. Outcome analysis of 9-gauge MRI-guided vacuum-assisted core needle breast biopsies. AJR Am J Roentgenol 2012;198:292-299
  35. Lee JM, Kaplan JB, Murray MP, Bartella L, Morris EA, Joo S, et al. Imaging histologic discordance at MRI-guided 9-gauge vacuum-assisted breast biopsy. AJR Am J Roentgenol 2007;189:852-859
  36. Malhaire C, El Khoury C, Thibault F, Athanasiou A, Petrow P, Ollivier L, et al. Vacuum-assisted biopsies under MR guidance: results of 72 procedures. Eur Radiol 2010;20:1554-1562
  37. Eby PR, Ochsner JE, DeMartini WB, Allison KH, Peacock S, Lehman CD. Frequency and upgrade rates of atypical ductal hyperplasia diagnosed at stereotactic vacuum-assisted breast biopsy: 9-versus 11-gauge. AJR Am J Roentgenol 2009;192:229-234
  38. Jackman RJ, Burbank F, Parker SH, Evans WP 3rd, Lechner MC, Richardson TR, et al. Stereotactic breast biopsy of nonpalpable lesions: determinants of ductal carcinoma in situ underestimation rates. Radiology 2001;218:497-502
  39. Lee SH, Kim EK, Kim MJ, Moon HJ, Yoon JH. Vacuum-assisted breast biopsy under ultrasonographic guidance: analysis of a 10-year experience. Ultrasonography 2014;33:259-266
  40. Orel SG, Rosen M, Mies C, Schnall MD. MR imaging-guided 9-gauge vacuum-assisted core-needle breast biopsy: initial experience. Radiology 2006;238:54-61
  41. Gao Y, Bagadiya NR, Jardon ML, Heller SL, Melsaether AN, Toth HB, et al. Outcomes of preoperative MRI-guided needle localization of nonpalpable mammographically occult breast lesions. AJR Am J Roentgenol 2016;207:676-684
  42. Raj SD, Agrons MM, Woodtichartpreecha P, Kalambo MJ, Dogan BE, Le-Petross H, et al. MRI-guided needle localization: indications, tips, tricks, and review of the literature. Breast J 2019;25:479-483